Erlotinib antagonizes constitutive activation of SRC family kinases and mTOR in acute myeloid leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Erlotinib antagonizes constitutive activation of SRC family kinases and mTOR in acute myeloid leukemia

Published:2011-09-15 Issue:18 Volume:10 Page:3168-3175
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Boehrer Simone,Galluzzi Lorenzo,Lainey Elodie,Bouteloup Cyrielle,Tailler Maximilien,Harper Francis,Pierron Gérard,Adès Lionel,Thépot Sylvain,Sébert Marie,Gardin Claude,de Botton Stéphane,Fenaux Pierre,Kroemer Guido

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

http://www.tandfonline.com/doi/pdf/10.4161/cc.10.18.16599

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Osimertinib Covalently Binds to CD34 and Eliminates Myeloid Leukemia Stem/Progenitor Cells;Cancer Research;2023-12-14

2. Novel inhibitor of hematopoietic cell kinase as a potential therapeutic agent for acute myeloid leukemia;Cancer Immunology, Immunotherapy;2022-01-18

3. Is the EGFR pathway relevant for the pathogenesis but not for treatment of acute myeloid leukemia?;Journal of Cancer Metastasis and Treatment;2021

4. Screening of prognostic risk microRNAs for acute myeloid leukemia;Hematology;2018-05-19

5. HIF-1α and mTOR – Possible Novel Strategies of Targeted Therapies in p16-positive and -negative HNSCC;Cancer Genomics & Proteomics;2018-04-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP